CI vs RANI · P/E 2.4, rev $274.90B vs rev $1.0M
Cigna Corp (CI) versus Rani Therapeutics Holdings Inc (RANI) — a side-by-side from cached financials, not a winner call.
Cigna Corp (CI) is a healthcare plans company listed on US.
Rani Therapeutics Holdings Inc (RANI) is a biotechnology company listed on US.
Latest reported CI revenue for 2025-12-31 was $274.90B. Net income was $5.96B. Revenue was up 11.2% from 2024-12-31 to 2025-12-31. CI currently screens at market cap $71.62B and trailing P/E 2.4.
Latest reported RANI revenue for 2024-12-31 was $1.0M. Net income was -$56.6M. RANI currently screens at market cap $41.5M.
CI currently screens at market cap $71.62B and trailing P/E 2.4. RANI currently screens at market cap $41.5M.
Not investment advice. Open the CI and RANI stock pages for the full models.
Not investment advice.